AKT1 |
P31749
|
AKT serine/threonine kinase 1
|
Kinase
|
0.98 |
0.311 |
0.962 |
BCL10 |
O95999
|
BCL10 immune signaling adaptor
|
|
0.34 |
0.491 |
0.769 |
BRAF |
P15056
|
B-Raf proto-oncogene, serine/threonine kinase
|
Kinase
|
1.00 |
0.319 |
0.846 |
CCL5 |
P13501
|
C-C motif chemokine ligand 5
|
Signaling
|
1.8E-03 |
0.403 |
0.885 |
CCND1 |
P24385
|
cyclin D1
|
Enzyme modulator
|
0.89 |
0.344 |
0.923 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
CDKN2A |
P42771 Q8N726
|
cyclin dependent kinase inhibitor 2A
|
|
0.39 |
0.300 |
0.885 |
CDKN2B |
P42772
|
cyclin dependent kinase inhibitor 2B
|
|
7.3E-03 |
0.417 |
0.769 |
DPP4 |
P27487
|
dipeptidyl peptidase 4
|
Enzyme
|
7.3E-09 |
0.420 |
0.808 |
EBI3 |
Q14213
|
Epstein-Barr virus induced 3
|
Signaling
|
0.11 |
0.474 |
0.808 |
FAS |
P25445
|
Fas cell surface death receptor
|
|
0.81 |
0.372 |
0.923 |
IFNG |
P01579
|
interferon gamma
|
|
0.47 |
0.288 |
0.962 |
IL10 |
P22301
|
interleukin 10
|
|
5.9E-03 |
0.281 |
0.923 |
IL17A |
Q16552
|
interleukin 17A
|
|
4.3E-02 |
0.324 |
0.923 |
IL18R1 |
Q13478
|
interleukin 18 receptor 1
|
Receptor
|
8.6E-06 |
0.473 |
0.808 |
IL22 |
Q9GZX6
|
interleukin 22
|
|
1.9E-04 |
0.393 |
0.885 |
IL5 |
P05113
|
interleukin 5
|
|
5.7E-03 |
0.437 |
0.846 |
JAK3 |
P52333
|
Janus kinase 3
|
Kinase
|
5.9E-06 |
0.505 |
0.731 |
JUNB |
P17275
|
JunB proto-oncogene, AP-1 transcription factor subunit
|
Transcription factor
|
0.86 |
0.467 |
0.769 |
JUND |
P17535
|
JunD proto-oncogene, AP-1 transcription factor subunit
|
Transcription factor
|
0.70 |
0.475 |
0.808 |
MIR155 |
|
microRNA 155
|
|
|
0.384 |
0.885 |
MYC |
P01106
|
MYC proto-oncogene, bHLH transcription factor
|
Transcription factor
|
1.00 |
0.344 |
0.923 |
NR0B2 |
Q15466
|
nuclear receptor subfamily 0 group B member 2
|
Nuclear receptor
|
8.3E-06 |
0.474 |
0.808 |
NTRK1 |
P04629
|
neurotrophic receptor tyrosine kinase 1
|
Kinase
|
2.0E-06 |
0.422 |
0.808 |
PTPN6 |
P29350
|
protein tyrosine phosphatase non-receptor type 6
|
|
1.00 |
0.485 |
0.769 |